Serono Symposia International Foundation adheres to guidelines of the European Accreditation Council for Continuing Medical Education (EACCME) and all other professional organizations, as applicable, which state that programs awarding continuing education credits must be balanced, independent, objective, and scientifically rigorous. Investigative and other uses for pharmaceutical agents, medical devices, and other products (other than those uses indicated in approved product labeling/package insert for the product) may be presented in the program (which may reflect clinical experience, the professional literature or other clinical sources known to the presenter). We ask all presenters to provide participants with information about relationships with pharmaceutical or medical equipment companies that may have relevance to their lectures. This policy is not intended to exclude faculty who have relationships with such companies; it is only intended to inform participants of any potential conflicts so that participants may form their own judgements, based on full disclosure of the facts. Further, all opinions and recommendations presented during the program and all program-related materials neither imply an endorsement nor a recommendation on the part of Serono Symposia International Foundation. All presentations represent solely the independent views of the presenters/authors.
The following faculty provided information regarding significant commercial relationships and/or discussions of investigational or non-EMEA/FDA approved (off-label) uses of drugs:
Amaya Belanger-Quintana Declared no potential conflict of interest.
Nenad Blau Declared to be member of Merck Serono Germany advisory board.
Alberto Burlina Declared to be member of the SAB Kamper Study.
Jaime Campistol Plana Declared no potential conflict of interest.
Chiara Cazzorla Declared no potential conflict of interest.
Uta Ceglarek Declared no potential conflict of interest.
Maureen Clearly Declared receipt of honoraria or consultation fees related to the EPG Committee work and to be member of the EPG Group.
Turgay Coskun Declared no potential conflict of interest.
Serwet Demirdas Declared no potential conflict of interest.
Mübeccel Demirkol Declared no potential conflict of interest.
François Feillet Declared receipt of honoraria or consultation fees from Merck Serono and Nutricia and to be member of Merck Serono, Shire and Nutricia advisory boards.
Ehud Gazit Declared no potential conflict of interest.
K. Michael Gibson Declared no potential conflict of interest.
Niels Gregersen Declared no potential conflict of interest.
Cary O. Harding Declared receipt of grants and contracts, honoraria or consultation fees from BioMarin Corp. Novato, CA and that his presentation will include discussion on off-labeled or otherwise non-approved uses of products, i.e. progress on clinical trials of an investigational drug.
Stephan Huijbregts Declared receipt of grants and contracts from NutsOhra Foundation, PKU Research Foundation, European Society for PKU (ESPKU) and of honoraria or consultation fees from Merck Serono S.A.
Anita MacDonald Declared receipt of grants and contracts, of honoraria or consultation fees from Nutricia, Vitaflo and Merck Serono and to be member of Vitaflo and Merck Serono advisory boards.
Ania C. Muntau Declared receipt of grants and contracts from Merck Serono and Vitaflo, of honoraria or consultation fees from Merck Serono and to be member of Merck Serono advisory board.
Júlio César Rocha Declared to be member of the European Nutritionist Expert Panel in PKU of Merck Serono.
Francjan J. van Spronsen Declared receipt of grants and contracts, honoraria or consultation fees from Merck Serono and Nutricia, to be member of Merck Serono and Nutricia advisory boards and that his presentation will include discussion on off-labeled or otherwise non-approved uses of products.
Ursula Wachtel Declared no potential conflict of interest.
Josef Weglage Declared no potential conflict of interest.
The following faculty have provided no information regarding significant relationship with commercial supporters and/or discussion of investigational or non-EMEA/FDA approved (off-label) uses of drugs as of 28 February 2013.
Karen Anjema
Maria Gizewska
Rianne Jahja
François Maillot
Priscila Mazzola
Ben Pode-Shakked
D.D. Reiss
Friedrich K. Trefz
Arnaud Wiedemann-Fodé